These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23339052)

  • 41. Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate.
    Zhang L; Zhang R; Yang J; Wang J; Kopeček J
    J Control Release; 2016 Aug; 235():306-318. PubMed ID: 27266365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-association properties of HPMA copolymers containing an amphipathic heptapeptide.
    Ding H; Kopecková P; Kopecek J
    J Drug Target; 2007; 15(7-8):465-74. PubMed ID: 17671893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity.
    Etrych T; Subr V; Strohalm J; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2012 Dec; 164(3):346-54. PubMed ID: 22759979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poly(styrene-alt-maleic anhydride)-based diblock copolymer micelles exhibit versatile hydrophobic drug loading, drug-dependent release, and internalization by multidrug resistant ovarian cancer cells.
    Baranello MP; Bauer L; Benoit DS
    Biomacromolecules; 2014 Jul; 15(7):2629-41. PubMed ID: 24955779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.
    Demoy M; Minko T; Kopecková P; Kopecek J
    J Control Release; 2000 Oct; 69(1):185-96. PubMed ID: 11018556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.
    Minko T; Kopecková P; Kopecek J
    Pharm Res; 1999 Jul; 16(7):986-96. PubMed ID: 10450921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
    Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
    Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer.
    Kopansky E; Shamay Y; David A
    J Drug Target; 2011 Dec; 19(10):933-43. PubMed ID: 22074249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates.
    Kasuya Y; Lu ZR; Kopecková P; Tabibi SE; Kopecek J
    Pharm Res; 2002 Feb; 19(2):115-23. PubMed ID: 11883637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.
    Malugin A; Kopecková P; Kopecek J
    J Control Release; 2007 Dec; 124(1-2):6-10. PubMed ID: 17869367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation.
    Chytil P; Etrych T; Kříž J; Subr V; Ulbrich K
    Eur J Pharm Sci; 2010 Nov; 41(3-4):473-82. PubMed ID: 20696244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death.
    Sirova M; Kabesova M; Kovar L; Etrych T; Strohalm J; Ulbrich K; Rihova B
    Curr Med Chem; 2013; 20(38):4815-26. PubMed ID: 24083609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
    Randárová E; Nakamura H; Islam R; Studenovský M; Mamoru H; Fang J; Chytil P; Etrych T
    Acta Biomater; 2020 Apr; 106():256-266. PubMed ID: 32058082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.
    Minko T; Kopecková P; Pozharov V; Kopecek J
    J Control Release; 1998 Jul; 54(2):223-33. PubMed ID: 9724909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
    Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
    Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy.
    Greish K; Ray A; Bauer H; Larson N; Malugin A; Pike D; Haider M; Ghandehari H
    J Control Release; 2011 May; 151(3):263-70. PubMed ID: 21223983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat.
    Yeung TK; Hopewell JW; Simmonds RH; Seymour LW; Duncan R; Bellini O; Grandi M; Spreafico F; Strohalm J; Ulbrich K
    Cancer Chemother Pharmacol; 1991; 29(2):105-11. PubMed ID: 1760851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting.
    Etrych T; Strohalm J; Chytil P; Černoch P; Starovoytova L; Pechar M; Ulbrich K
    Eur J Pharm Sci; 2011 Apr; 42(5):527-39. PubMed ID: 21392579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
    Zhou Z; Li L; Yang Y; Xu X; Huang Y
    Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.